Changes in hypertension treatment and in congestive heart failure mortality in the United States.

Author:

Yusuf S1,Thom T1,Abbott R D1

Affiliation:

1. Clinical Trials Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892.

Abstract

The use of antihypertensive agents has increased in recent years and has been more marked among individuals in older age groups (65-74 years) than in middle-aged groups (45-54 years). Because hypertension is a strong risk factor for the development of congestive heart failure, more common use of antihypertensive agents would be expected to reduce the incidence of congestive heart failure. Examination of the national death statistics reveals decreases in congestive heart failure mortality at younger ages with mortality increases at older ages. The reasons for these divergent trends in congestive heart failure mortality in different ages and the apparent inconsistency with respect to the changes in the use of antihypertensive drugs are explored. We speculate that antihypertensive treatment does not completely prevent congestive heart failure but merely postpones its development by several decades.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference15 articles.

1. Role of Blood Pressure in the Development of Congestive Heart Failure

2. Effect of Drug Therapy on Survival in Chronic Heart Failure

3. National Center for Health Statistics Drizd T Dannenberg AL Engel A: Blood pressure levels in persons 18-74 years of age in 1976-1980 and trends in BP from 1960-1980 in the United States in Vital and Health Statistics Series 11 No. 234 Dept of Health and Human Services publication No. (PHS) 86-1684. Public Health Service Washington DC US Government Printing Office July 1986 pp 1-68

4. Hamilton M Thomson EN Wisniewski TKM: The role of blood-pressure control in preventing complications of hypertension. Lancet 1960;l:235-238

5. Effects of treatment in hypertension results of a controlled study

Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3